US Broker Ratings

PACS Group, Inc. (PACS): An Investor’s Outlook on Healthcare’s Rising Star with a 37% Upside

PACS Group, Inc. (PACS), a prominent player in the healthcare sector specializing in medical care facilities, has been catching the eye of investors with its impressive growth trajectory and substantial..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 114.68% Potential Upside in Biotech Innovation

Investors eyeing opportunities in the biotechnology sector may find NewAmsterdam Pharma Company N.V. (NAMS) an intriguing proposition. With a market capitalization of $2.82 billion, this Netherlands-based biotech firm is making..

Phreesia, Inc. (PHR) Stock Analysis: Uncovering a 39.27% Upside Potential in Healthcare SaaS

Phreesia, Inc. (NYSE: PHR) is making waves in the healthcare sector with its innovative SaaS-based platform aimed at revolutionizing patient engagement and administrative processes for healthcare providers. With a market..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Promising 18.64% Upside Potential

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, has captured investor attention with its innovative solutions in the medical devices industry. Headquartered in Newburyport, Massachusetts, UFPT’s..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 100% Upside Opportunity

For investors keeping a close eye on the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing proposition. The company, headquartered in Hampton, New Jersey, specializes in developing therapeutic..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 37.06% Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine oncology, drawing keen interest from investors due to its promising therapeutic pipeline and a significant potential upside of..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a 63.81% Potential Upside in the Biotech Arena

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out in the biotechnology sector with a promising range of RNA interference therapies targeting intractable diseases. The company’s innovative pipeline and strategic partnerships position..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a 43% Upside Potential Amid Innovative Biotech Advances

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the healthcare sector, particularly within the biotechnology industry. As a company dedicated to pioneering treatments for rare and debilitating neuromuscular..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 115% Potential Upside in the Biotechnology Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) stands out in the biotechnology sector with its ambitious pursuit of precision genetic medicines. Based in Cambridge, Massachusetts, this innovative company is rapidly developing treatments..

Sotera Health Company (SHC) Stock Analysis: Exploring a 23% Upside Potential in the Healthcare Sector

Sotera Health Company (SHC), a prominent player in the healthcare sector’s diagnostics and research industry, is garnering attention with its robust market position and potential upside. Headquartered in Broadview Heights,..

Adaptive Biotechnologies Corp (ADPT): Investor Outlook on a Healthcare Innovator with Promising Growth Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the forefront of innovation in the healthcare sector, specifically within the Diagnostics & Research industry. Headquartered in Seattle, Washington, Adaptive Biotechnologies is renowned..

Immunocore Holdings plc (IMCR) Stock Analysis: Unpacking a 103.98% Potential Upside

Investors with a keen eye on the biotechnology sector should take a closer look at Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biopharmaceutical company specializing in innovative immunomodulating treatments. With..

BGM Group Ltd. (BGM): Valuation Insights for Investors Amidst Rapid Revenue Growth

BGM Group Ltd. (BGM), a Chinese pharmaceutical and chemical company, has recently attracted the attention of investors and analysts alike due to its impressive revenue growth. Operating in the healthcare..

Certara, Inc. (CERT) Stock Analysis: Navigating Healthcare Tech with a Cautious Outlook

Certara, Inc. (NASDAQ: CERT) operates at the intersection of healthcare and technology, specializing in biosimulation to aid drug discovery and development processes. With a market capitalization of $1.39 billion, this..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 19.34% Potential Upside in the Volatile Health Information Services Sector

GoodRx Holdings, Inc. (NASDAQ: GDRX) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Santa Monica, California, the company has carved out..

PTC Therapeutics, Inc. (PTCT): Investor Outlook on a Biotech Innovator Poised for 54% Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT) presents a compelling opportunity for investors with a keen interest in the biotechnology sector, particularly those focused on companies pioneering treatments for rare disorders. As..

Xenon Pharmaceuticals Inc. (XENE): Investor Outlook with a 102% Potential Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a neuroscience-focused biopharmaceutical company headquartered in Burnaby, Canada, is capturing the attention of investors with its promising pipeline and significant growth potential. As a player..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating a 29.98% Potential Upside in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, presents an intriguing investment opportunity with a potential upside of 29.98%. With a market capitalization of $2.16..

PGIM Securitized Income ETF (PINC) Stock Analysis: Navigating Stability with a $4.07 Billion Market Cap

In a financial landscape often characterized by volatility and uncertainty, the PGIM Securitized Income ETF (NYSEARCA: PINC) stands out for its steady approach to investing. With a robust market capitalization..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 34.86% Potential Upside

Progyny, Inc. (PGNY), a prominent player in the healthcare plans sector, is redefining fertility and family-building benefits in the United States. With a market capitalization of $1.96 billion, Progyny offers..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds